HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.

Autor: Reusing SB; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Manser AR; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Groeneveld-Krentz S; Department of Paediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany., Rebmann V; Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany., Horn PA; Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany., Meisel R; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Karawajew L; Department of Paediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany., Borkhardt A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Uhrberg M; Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University, Düsseldorf, Germany., Babor F; Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. Florian.Babor@med.uni-duesseldorf.de.
Jazyk: angličtina
Zdroj: Bone marrow transplantation [Bone Marrow Transplant] 2021 Jul; Vol. 56 (7), pp. 1723-1727. Date of Electronic Publication: 2021 Mar 03.
DOI: 10.1038/s41409-021-01231-y
Databáze: MEDLINE